Stabilized trimeric class I fusion proteins patent application
Summary
The USPTO has published a patent application (US20260085096A1) for stabilized trimeric class I fusion proteins. The application details specific mutations in the HR2 domain to enhance protein stability. This is a routine publication of a new patent application.
What changed
This document is a publication of a patent application filed by inventors Johannes Petrus Maria LANGEDIJK, Mark Johannes Gerardus BAKKERS, Annemart KOORNNEEF, and Jaroslaw JURASZEK. The application, titled 'Stabilized trimeric class I fusion proteins,' describes novel fusion proteins with stabilizing mutations in the HR2 domain, potentially impacting the development of new therapeutic proteins.
As this is a patent application publication, there are no immediate compliance obligations for regulated entities. However, companies in the pharmaceutical and biotechnology sectors should monitor this application and related patents for potential future intellectual property considerations and competitive landscape analysis. The application was filed on September 15, 2023, and published on March 26, 2026.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
STABILIZED TRIMERIC CLASS I FUSION PROTEINS
Application US20260085096A1 Kind: A1 Mar 26, 2026
Inventors
Johannes Petrus Maria LANGEDIJK, Mark Johannes Gerardus BAKKERS, Annemart KOORNNEEF, Jaroslaw JURASZEK
Abstract
The present invention relates to trimeric class I fusion proteins, in particular to class I fusion proteins, comprising at least one stabilizing mutation in the HR2 domain, and to fragments thereof.
CPC Classifications
C07K 14/005 C12N 15/86 C12N 2710/10343 C12N 2760/18222 C12N 2760/18622 C12N 2770/20022
Filing Date
2023-09-15
Application No.
19113685
Related changes
Get daily alerts for USPTO Patent Applications - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.